D. Russo

R. Fanin, A. Bosi, A. Bacigalupo, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016‐B survey

N. Toschi, L. Pagano, G. Nadali, 2021, Mycoses.

elderly patients with chronic myeloid leukemia Effects and outcome of a policy of intermittent imatinib treatment in

M. Baccarani, G. Rosti, G. Martinelli, 2013 .

SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia.

J. Radich, J. Melo, G. Martinelli, 2011, Blood.

Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.

R. Fanin, M. Baccarani, D. Russo, 1996, Haematologica.

Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing

M. Chiarini, A. Roccaro, A. Sacco, 2017, Current Osteoporosis Reports.

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients

R. Foà, M. Gobbi, P. Mazza, 2011, Leukemia & lymphoma.

Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response.

S. Paolini, G. Martinelli, M. Luppi, 2014, Leukemia research.

Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement

M. Baccarani, S. Paolini, G. Martinelli, 2014, Cancer.

Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation.

R. Fanin, M. Baccarani, S. Tura, 1999, Journal of Clinical Oncology.

Bortezomib as an antitumor agent.

D. Ribatti, P. Richardson, F. Dammacco, 2006, Current pharmaceutical biotechnology.

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres

L. Mele, L. Pagano, A. Nosari, 2002, British journal of haematology.

Interferon-alfa for chronic myeloid leukemia.

M. Baccarani, G. Rosti, G. Martinelli, 2003, Seminars in hematology.

A randomized study of interferon- a versus interferon- a and low-dose arabinosyl cytosine in chronic myeloid leukemia

M. Baccarani, G. Rosti, G. Martinelli, 2002 .

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study

M. Baccarani, G. Rosti, S. Russo, 2021, Cancer medicine.

Cancer Therapy : Clinical Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and / or Erythropoietin Unresponsive Patients with Low / INT-1 – Risk Myelodysplastic Syndromes

M. Gobbi, R. Fanin, G. Martinelli, 2013 .

Treosulfan compared with reduced‐intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial

U. Pichlmeier, D. Niederwieser, P. Dreger, 2022, American journal of hematology.

Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line?

D. Russo, M. Malagola, S. Bernardi, 2017 .

Leukemia and multi-drug resistance: too many mechanisms of drug resistance or too many doctors resistant?

M. Baccarani, D. Russo, M. Malagola, 2009, Leukemia & lymphoma.

Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients

M. Baccarani, G. Rosti, G. Martinelli, 2016, Oncotarget.

Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer

A. Falanga, D. Russo, F. Schieppati, 2015, Seminars in Thrombosis & Hemostasis.

Preliminary report of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin in patients with acute myeloid leukemia

J. Esteve, M. Berger, M. Tallman, 2001 .

PEG Intron Treatment in 90 Patients with Essential Thrombocythemia (ET) Final Report of a Phase II Study.

M. Gobbi, R. Fanin, P. Mazza, 2005 .

Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells.

R. Fanin, M. Baccarani, D. Russo, 1996, Leukemia & lymphoma.

Sensitivity of Ph1+ CFU-GM to human recombinant interferon α and γ alone and in combination

R. Fanin, M. Baccarani, S. Tura, 1988, Blut: Zeitschrift für die Gesamte Blutforschung.

In Vitro Activity of Alpha-Interferon on Granulocyte-Macrophage Precursors in Chronic Myeloid Leukemia (CML): Correlation with Clinical Responsiveness

R. Fanin, M. Santucci, S. Tura, 1992 .

Experts’ considerations on HLA‐haploidentical stem cell transplantation

R. Fanin, M. Martelli, A. Bosi, 2014, European journal of haematology.

The Role of Granulocyte Colony-Stimulating Factor (Filgrastim) in Maintaining Dose Intensity during Conventional-Dose Chemotherapy with Abvd in Hodgkin's Disease

R. Fanin, M. Baccarani, G. Barillari, 1994, Tumori.

Efficacy and toxicity of FLAI vs ICE for induction treatment of newly diagnosed AML patients, younger than 60 years

M. Gobbi, R. Fanin, P. Mazza, 2004 .

In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia

S. Pileri, A. Vitale, P. Pelicci, 2015, Journal of Hematology & Oncology.

Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on ‘in vitro’ growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors

M. Baccarani, E. Ottaviani, S. Tura, 1997, Leukemia.

Disposition of Liposomal Daunorubicin During Cotreatment with Cytarabine in Patients with Leukaemia

R. Fanin, M. Baccarani, F. Pea, 2003, Clinical pharmacokinetics.

GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS

P. Mazza, V. Pavone, P. Chiusolo, 2021, Transplantation and Cellular Therapy.

Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit

Federica Re, D. Russo, M. Malagola, 2020, Frontiers in Oncology.

‘Real-life’ analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study

L. Pagano, F. Aversa, G. Nadali, 2019, The Journal of antimicrobial chemotherapy.

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

P. Chiusolo, A. Nagler, A. Bosi, 2015, The Lancet. Oncology.

Timely Leukapheresis May Interfere with the “Fitness” of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients

Federica Re, S. Piva, D. Russo, 2022, Cancers.

Interim analysis of a phase II study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine and daunorubicin to patients < 60 years old with untreated acute myeloid leukemia.

M. Berger, G. Juliusson, M. Tallman, 2002 .

Rituximab for the treatment of type II mixed cryoglobulinemia.

R. Fanin, M. Baccarani, S. De Vita, 2002, Arthritis and rheumatism.

B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.

R. Fanin, M. Baccarani, S. De Vita, 2002, Haematologica.

Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases

M. Gobbi, R. Fanin, P. Mazza, 2008, European journal of haematology.

Central nervous system angiitis in Hodgkin’s disease

A. Padovani, A. Pezzini, A. Morotti, 2013, Journal of Neurology.

BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.

R. Fanin, M. Baccarani, C. di Loreto, 1998, Leukemia & lymphoma.

A Systematic Review of the Literature and Perspectives on the Role of Biomarkers in the Management of Malnutrition After Allogeneic Hematopoietic Stem Cell Transplantation

D. Russo, F. Arena, M. Malagola, 2021, Frontiers in Immunology.

Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase

P. Galieni, S. Sacchi, G. Avvisati, 1998, Leukemia.

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy

M. Baccarani, G. Martinelli, G. Saglio, 2000, Bone Marrow Transplantation.

Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy

R. Fanin, M. Baccarani, S. Tura, 1991, Annals of Hematology.

The role of MDR‐related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype

R. Fanin, E. Calistri, D. Russo, 2007, Hematological oncology.

FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience

R. Fanin, D. Russo, M. Tiribelli, 2009, American journal of hematology.

Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α

R. Fanin, M. Baccarani, G. Martinelli, 1996 .

Liposomal daunorubicin plus cytosine arabinoside for elderly patients with acute myeloid leukemia: The gimema experience

M. Baccarani, M. Vignetti, F. Mandelli, 2000 .

Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL).

S. Tura, P. Tosi, D. Russo, 1989, Haematologica.

D. Russo, F. Zaja, A. Candoni, 2022 .

Identiﬁcation and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1 –positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell’Adulto Acute Leukemia Working Party (GIMEMAAL WP)

R. Foà, M. Baccarani, S. Chiaretti, 2009 .

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

S. Montoto, N. Kröger, A. Nagler, 2018, Bone Marrow Transplantation.

Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia.

A. Guarini, S. Tura, D. Russo, 2009, Scandinavian journal of haematology.

Postremission sequential monitoring of minimal residual disease by WT1 Q‐PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk‐adapted therapy in acute myeloid leukemia patients

M. Chiarini, G. Ruggeri, G. Rossi, 2015, Cancer medicine.

Editorial: Strengths and Challenges of Allo-SCT in the Modern Era

M. Mohty, F. Ciceri, D. Russo, 2022, Frontiers in Oncology.

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

P. Chiusolo, E. Lanino, A. Bosi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice

L. Pagano, D. Russo, B. Rambaldi, 2016, Mediterranean journal of hematology and infectious diseases.

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

A. Ferrario, M. De Gobbi, M. Marcatti, 2021, Bone Marrow Transplantation.

Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.

T. Barbui, M. Robin, I. Yakoub-Agha, 2022, The Lancet. Haematology.

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

G. Corrao, F. Gherlinzoni, P. Galieni, 2020, The Lancet Haematology.

The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era

C. Pristipino, D. Russo, M. Malagola, 2018, Blood research.

Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient

D. Russo, M. A. Francesco, A. Caruso, 2018, Clinical Microbiology Newsletter.

Clinical and Biological Aspects of Essential Thrombocythemia

M. Baccarani, P. Mannucci, A. Guarini, 1985 .

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.

Sante Tura, R. Fanin, M. Baccarani, 1994, The New England journal of medicine.

Multicentre phase III trial on fludarabine, cytarabine (Ara‐C), and idarubicin versus idarubicin, Ara‐C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients

R. Fanin, P. Mazza, M. Baccarani, 2005, British journal of haematology.

Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: The value of early evaluation of the course of the disease

Rizzoli, R. Fanin, P. Galieni, 2005, Annals of Hematology.

Pregnancy and abortion in women with essential thrombocythemia

R. Fanin, D. Russo, A. Candoni, 2002, American journal of hematology.

Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer

A. Di Paolo, D. Russo, F. Bondanini, 2022, Journal of clinical medicine.

EPIDEMIOLOGICAL, DIAGNOSTIC, THERAPEUTIC AND PROGNOSTIC ASPECTS OF ESSENTIAL THROMBOCYTHEMIA IN RETROSPECTIVE STUDY OF THE GIMMC GROUP IN TWO THOUSAND PATIENTS

S. Sacchi, V. Martinelli, M. Mazzucconi, 1997 .

Spinal cord compression by extramedullary hematopoietic tissue in a thalassemic patient: prompt effect of radiotherapy.

S. Pileri, B. Bernardi, E. Barbieri, 1989, Haematologica.

Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain.

M. Iacono, A. Kohlmann, T. Haferlach, 2013, Blood.

ABL populations by ultra-deep sequencing of the resistant − Unraveling the complexity of tyrosine kinase inhibitor

M. Iacono, A. Kohlmann, T. Haferlach, 2013 .

Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes

M. Gobbi, J. McCubrey, G. Martinelli, 2019, Leukemia.

Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients

P. Quaglino, D. Russo, N. Zarovni, 2020, Scientific Reports.

Hypoxia-induced down-modulation of PKCε promotes trail-mediated apoptosis of tumor cells

M. Vitale, C. Micheloni, L. Cocco, 2010 .

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

R. Foà, M. Baccarani, S. Chiaretti, 2009, Blood.

A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.

Sante Tura, Giovanni Martinelli, Giuseppe Saglio, 2002, Blood.

Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?

D. Russo, M. Malagola, S. Bernardi, 2020, Frontiers in Oncology.

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias

P. Richardson, S. Treon, A. Roccaro, 2008, Biologics : targets & therapy.

Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferons.

R. Fanin, M. Baccarani, D. Russo, 1994, Haematologica.

ALL-TRANS RETINOIC ACID IN HEMATOLOGICAL MALIGNANCIES

S. Sacchi, G. Avvisati, P. Pelicci, 2022 .

Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia

Federica Re, D. Russo, C. Foroni, 2019, International journal of molecular medicine.

Zebrafish disease models in hematology: Highlights on biological and translational impact.

G. Borsani, E. Monti, M. Presta, 2019, Biochimica et biophysica acta. Molecular basis of disease.

P‐glycoprotein, lung resistance‐related protein and multidrug resistance‐associated protein in de novo adult acute lymphoblastic leukaemia

R. Fanin, M. Baccarani, D. Russo, 2002, British journal of haematology.

Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy : additional analyses from the AFFIRM randomized clinical trial

F. Stagno, A. Cuneo, M. Gobbi, 2014 .

Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin

R. Fanin, F. Gherlinzoni, M. Baccarani, 2012, The Pharmacogenomics Journal.

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia.

M. Baccarani, G. Rosti, G. Martinelli, 2013, Blood.

Case–control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients

M. Gobbi, R. Fanin, P. Mazza, 2007, British journal of haematology.

In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants

M. Baccarani, G. Rosti, G. Martinelli, 2016, BMC Cancer.

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment

M. Baccarani, G. Martinelli, S. Russo, 2015, Blood Cancer Journal.

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

M. Baccarani, F. Mandelli, G. Martinelli, 2014, American journal of hematology.

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.

Giovanni Martinelli, Arnon Nagler, Giovanna Rege-Cambrin, 2009, Blood.

Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells)

G. Borsani, C. Gemelli, S. Ferrari, 2017, PloS one.

Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.

N. Kröger, J. Sierra, A. Nagler, 2019, The Lancet. Haematology.

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.

Giuseppe Milone, Stefano Guidi, Arnon Nagler, 2016, The New England journal of medicine.

Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

R. Fanin, M. Baccarani, G. Barillari, 1996, Blood.

Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.

S Quaglini, G Barosi, A Centra, 1998, Blood.

Evaluating survival after allogeneic bone marrow transplant for chronic myeloid leukaemia in chronic phase: a comparison of transplant versus no‐transplant in a cohort of 258 patients first seen in Italy between 1984 and 1986

Rizzoli, R. Fanin, P. Galieni, 1993, British journal of haematology.

Advances in CMV Management: A Single Center Real-Life Experience

D. Russo, L. Signorini, A. Caruso, 2020, Frontiers in Cell and Developmental Biology.

Prospective Phase II Study on 5-Days Azacitidine for Treatment of Symptomatic and/or Erythropoietin Unresponsive Patients with Low/INT-1–Risk Myelodysplastic Syndromes

M. Gobbi, R. Fanin, G. Martinelli, 2013, Clinical Cancer Research.

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

N. Kröger, J. Sierra, A. Nagler, 2014 .

Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.

P. Chiusolo, A. Bosi, D. Russo, 2016, Transplantation.

EXTRACORPOREAL PHOTOPHERESIS (ECP) FOR TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: AN ITALIAN MULTICENTRIC RETROSPECTIVE ANALYSIS ON 94 PATIENTS ON BEHALF OF THE GRUPPO ITALIANO TRAPIANTO DI MIDOLLO OSSEO (GITMO).

P. Chiusolo, A. Bosi, D. Russo, 2016, Transplantation.

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎.

R. Latagliata, F. Aversa, A. Cuneo, 2018, Seminars in hematology.

Prevalence of Hepatitis C Virus Infection in Patients With L y m p hop r oii f e rat i ve Disorders

R. Fanin, G. Barillari, D. Russo, 2002 .

Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation

M. Chiarini, S. Martellos, D. Russo, 2017, PloS one.

Serum Lactate Dehydrogenase Fails to Predict Response to Treatment and Survival in Acute Non-lymphocytic Leukemia

R. Fanin, M. Baccarani, L. Mangoni, 1989, The International journal of biological markers.

Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation

G. Ruggeri, G. Rossi, L. Caimi, 2014, BioMed research international.

Positive HCMV DNAemia in stem cell recipients undergoing letermovir prophylaxis is expression of abortive infection

F. Baldanti, T. Lazzarotto, F. Ciceri, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients

R. Foà, A. Velardi, S. Santarone, 2019, Mediterranean journal of hematology and infectious diseases.

Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System

C. Almici, D. Russo, B. Bruno, 2019, Scientific Reports.

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

R. Fanin, F. Gherlinzoni, P. Galieni, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence?

F. Castelli, D. Russo, L. Signorini, 2017, Infection Control & Hospital Epidemiology.

Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience

C. Almici, A. Roccaro, F. Castelli, 2017, Mediterranean journal of hematology and infectious diseases.

The expression of the multidrug resistance‐associated glycoprotein in B‐cell chronic lymphocytic leukaemia

S. Pileri, G. Fasola, R. Fanin, 1991, British journal of haematology.

Quantitative Evaluation of BCR-ABL Amount of Transcript Post Mobilization with G-CSF of Peripheral Blood Stem Cells from Chronic Myeloid Leukemia Patients in Cytogenetic Response

G. Rosti, G. Martinelli, E. Ottaviani, 2000, Leukemia & lymphoma.

Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms

G. Borsani, E. Monti, D. Russo, 2021, Cells.

Profile of toll-like receptors on peripheral blood cells in relation to acute graft-versus-host disease after allogeneic stem cell transplantation.

E. Garrafa, D. Russo, C. Skert, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenström's Macroglobulinemia

F. Dammacco, S. Treon, A. Roccaro, 2008, Clinical Cancer Research.

The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions

S. Treon, A. Roccaro, A. Sacco, 2017, Oncotarget.

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

S. Montoto, P. Dreger, J. Passweg, 2019, Bone Marrow Transplantation.

Delayed and long-lasting complete response to fludarabine in two patients with B-cell chronic lymphocytic leukemia

M. Baccarani, D. Russo, F. Zaja, 1999, Annals of Hematology.

Combined therapy with Fludarabine and Cyclophosphamide in relapsed/resistant patients with B‐cell chronic lymphocytic leukaemia and non‐Hodgkin's lymphomas

D. Russo, F. Zaja, F. Silvestri, 1997, European journal of haematology.

Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?

P. Galieni, G. Avvisati, S. Tura, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

R. Latagliata, A. Cuneo, M. Krampera, 2020, British journal of haematology.

Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years

M. Chiarini, D. Russo, L. Imberti, 2018, Leukemia & lymphoma.

R. Fanin, M. Baccarani, F. Pea, 1995, Leukemia.

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers.

A. Santoro, L. Giordano, F. Ricci, 2015, The oncologist.

Phase II Study of Perifosine and Sorafenib Dual-Targeted Therapy in Patients with Relapsed or Refractory Lymphoproliferative Diseases

L. Giordano, A. Anichini, C. Carlo-Stella, 2014, Clinical Cancer Research.

Successful hematopoietic stem cell transplantation for complete CTLA-4 haploinsufficiency due to a de novo monoallelic 2q33.2-2q33.3 deletion.

V. Lougaris, A. Plebani, D. Russo, 2020, Clinical immunology.

Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha.

R. Fanin, D. Russo, N. Testoni, 1990, Haematologica.

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study.

R. Fanin, M. Baccarani, P. Piccaluga, 2007, Haematologica.

Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?

R. Fanin, M. Baccarani, P. Piccaluga, 2005, Blood.

Physicians Abstracts

J. Esteve, R. Unger, R. Unger, 2015, Bone Marrow Transplantation.

Favourable Outcome after Treosulfan Based Conditioning in Patients Undergoing an Allogeneic Hematopoietic Cell Transplantation (alloHCT) for the Treatment of Acute Myleloid Leukaemia (AML): A Subgroup Analysis of the Randomized Phase III MC-Fludt.14/L Trial

P. Dreger, E. Holler, C. Junghanss, 2022, Transplantation and Cellular Therapy.

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G‐CSF mobilization

A. Levis, G. Gaidano, C. Almici, 2015, Hematological oncology.

Prognostic factors in chronic myeloid leukemia. Relationship with interferon and bone marrow transplantation. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.

Rizzoli, R. Fanin, M. Baccarani, 1993, Leukemia & lymphoma.

Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study

P. Mazza, V. Pavone, P. Chiusolo, 2023, Transplantation direct.

Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients

M. Mohty, D. Russo, M. Malagola, 2020, Bone Marrow Transplantation.

Waldenström's Macroglobulinemia: new therapeutic options

A. Roccaro, I. Ghobrial, S. Blotta, 2008 .

How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation

D. Russo, L. Grazioli, M. Malagola, 2022, Cells.

Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

M. Robin, I. Yakoub-Agha, J. Snowden, 2022, Bone Marrow Transplantation.

Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas.

A. Santoro, L. Giordano, C. Carlo-Stella, 2021, Transplantation and cellular therapy.

Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with α‐interferon

M. Baccarani, G. Rosti, F. Bonifazi, 2000 .

Idiopathic Hypereosinophilic Syndrome (HES) with FIP1L1-PDGFRA Rearrangement Can Be Effectively Treated with Imatinib.

S. Pileri, M. Cazzola, M. Gobbi, 2004 .

Testing Sokal's and the new prognostic score for chronic myeloid leukaemia treated with alpha-interferon. Italian Cooperative Study Group on Chronic Myeloid Leukaemia.

M. Baccarani, G. Rosti, F. Bonifazi, 2000, British journal of haematology.

Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis

R. Fanin, R. Latagliata, E. Sabattini, 2017, Oncotarget.

Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome

G. Rossi, D. Russo, C. Carbone, 2019, Leukemia & lymphoma.

Management of Invasive Infections due to a Rare Arthroconidial Yeast, Saprochaete capitata, in Two Patients with Acute Hematological Malignancies

D. Russo, A. Caruso, M. D. De Francesco, 2021, Vaccines.

ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial

Federica Re, D. Russo, C. Foroni, 2020, Case reports in hematology.

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

I. Laurenzana, G. Martinelli, G. Perini, 2016, Oncotarget.

dsDNA from extracellular vesicles (EVs) in adult AML

D. Russo, M. Malagola, S. Bernardi, 2020, Annals of Hematology.

Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.

R. Fanin, M. Baccarani, D. Russo, 1997, Haematologica.

Laparoscopic Splenectomy in Idiopathic Thrombocytopenic Purpura

M. Baccarani, D. Russo, A. Donini, 1995, Vox sanguinis.

Low-Dose Rituximab in Idiopathic Autoimmune Hemolytic Anemia.

D. Consonni, A. Zanella, D. Russo, 2009 .

Human myeloid precursor cells do not possess or produce procoagulant activity (PCA).

A. Guarini, S. Tura, D. Russo, 1986, Experimental hematology.

Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia

M. Baccarani, F. Pea, D. Russo, 2000, Cancer Chemotherapy and Pharmacology.

Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosis

R. Fanin, R. Latagliata, E. Sabattini, 2017, Oncotarget.

Treatment of Ph+ chronic myeloid leukemia by gamma interferon

R. Fanin, M. Baccarani, S. Tura, 1989, Blut.

M. Baccarani, G. Rosti, G. Martinelli, 2016, BMC Cancer.

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation

M. Gobbi, G. Gaidano, F. Di Raimondo, 2019, Cancer medicine.

Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications

M. Baccarani, G. Rosti, G. Martinelli, 2012 .

Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma

R. Fanin, S. Tura, P. Tosi, 1990, Blut.

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

R. Fanin, G. Damante, D. Fabbro, 2010, Leukemia research.

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

R. Foà, R. Fanin, R. Latagliata, 2018, Annals of Hematology.

Multidrug resistance modulation in vivo: The effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia

R. Fanin, M. Baccarani, F. Pea, 1999, European Journal of Clinical Pharmacology.

p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives.

R. Fanin, M. Baccarani, D. Russo, 1994, Haematologica.

P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia.

R. Fanin, M. Baccarani, D. Russo, 1995, Leukemia & lymphoma.

Overexpression of multidrug resistance‐associated p170‐glycoprotein in acute non‐lymphocytic leukemia

S. Pileri, T. Tsuruo, R. Fanin, 1992, European journal of haematology.

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives

M. Baccarani, S. Soverini, D. Russo, 2020, Journal of clinical medicine.

Case Report Kaposi’s sarcoma occurring in a young black man after kidney transplantation

D. Russo, G. Palmiero, A. D. Blasio, 2005 .

A bronchoalveolar lavage‐driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group

L. Pagano, D. Russo, A. Busca, 2019, American journal of hematology.

Molecular analysis of PML‐RARa fusion mRNA detected by reverse transcription‐polymerase chain reaction assay in long‐term disease‐free acute promyelocytic leukaemia patients

G. Martinelli, S. Tura, D. Russo, 1995, British journal of haematology.

Digital PCR as a New Method for Minimal Residual Disease Monitoring and Treatment Free Remission Management in Chronic Myeloid Leukemia Patients: Is It Reliable?

Federica Re, D. Russo, M. Malagola, 2022, Hemato.

Final Evaluation of a Clinical Phase III Trial Comparing Treosulfan to Busulfan-Based Conditioning Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation of Adult Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients Ineligible to Standard Myeloablative Regimens

D. Niederwieser, P. Dreger, E. Holler, 2019, Biology of Blood and Marrow Transplantation.

Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia

M. Gobbi, P. Mazza, M. Baccarani, 2001, Leukemia and Lymphoma.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable – a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

A. Stamatoullas, M. Robin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Clinical experience of antibodies to interferon-alpha during treatment of chronic myeloid leukemia.

D. Russo, A. Candoni, R. Grattoni, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Prospective confirmation of a prognostic classification for Ph + chronic myeloid leukaemia

D. Russo, 1988, British journal of haematology.

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

F. Dammacco, S. Treon, A. Roccaro, 2007 .

Liposome encapsulated daunorubicin (daunoxome) for acute leukemia.

F. Pea, D. Russo, G. Visani, 2000, Haematologica.

Serum lactate dehydrogenase is an important risk determinant in acute lymphocytic leukemia.

G. Fasola, R. Fanin, D. Russo, 1989, Haematologica.

Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?

D. Russo, M. Malagola, S. Bernardi, 2020, Acta Haematologica.

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Letermovir (LET) Prophylaxis When Extended from 100 to 200 Days Post-Transplant in Cytomegalovirus (CMV)-Seropositive Recipients (R+) of an Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

D. Russo, B. Haber, M. Stelljes, 2023, Transplantation and Cellular Therapy.